top of page
    Search

    Low Dose Naltrexone (LDN)


    In certain clinical situations, I will implement low dose naltrexone (LDN) into my patient’s treatment plan.


    This isn’t a band-aid or masking symptoms, it is modulating the immune system.  Here’s how the medication works...


    LDN transiently blocks opioid receptors for a few hours, leading to a rebound increase in endogenous endorphins and enkephalins. This modulates immune function. It also acts as toll-like receptor 4 (TLR4) antagonist on microglia, reducing neuroinflammation and downstream cytokine signaling. 


    Off label uses:

    -Hashimoto’s thyroiditis

     -Graves’ disease

     -Rheumatoid arthritis

     -Systemic lupus erythematosus

     -Multiple sclerosis

     -Inflammatory bowel disease (Crohn’s, ulcerative colitis)

     -Psoriasis

     -Fibromyalgia and chronic fatigue syndrome


    Potential side effects:

    -Vivid dreams

    -GI upset 

    *May be an adjustment phase in the first 1-2 weeks. 

    *Opioid use is an absolute contraindication. 


    Duration:

    This is at the discretion of the provider, but can often times be safely used long-term. 


    When are results felt?

    I have seen as soon as 3 weeks, but I usually say give it 2 months if being used for pain or inflammation.   Depending on the goals and what it is being used for, the patient may not FEEL results. 


    Final thoughts:

    I always use this as supportive therapy, to give us synergistic effects while we address all the components of life-style and underlying drivers of inflammation. 


    As always, work with a trained Provider who can analyze all elements of your clinical picture. 

     
     
     

    Recent Posts

    See All
    TTC Bloodwork List:

    ESH, LH, ESTRADIOL AROUND CYCLE DAY 3 LUTEAL PROGESTERONE ABOUT 7 DAYS AFTER LH SPIKE TOTAL AND FREE TESTOSTERONE, SHBG, DHEA-S, PROLACTIN NUTRIENTS: COPPER, ZINC, VITAMIN B12, VITAMIN D, RBC MAGNE SI

     
     
     
    Peptides and the FDA

    There was an FDA Pharmacy Compounding Advisory Committee meeting in July 2026 discussing several peptides commonly used in functional and longevity medicine. The peptides discussed included: BPC 157 K

     
     
     

    Comments


    Office Phone Number:
    480.405.7138

    Email:
    bbuchanan@origofm.com

    Instagram:
    burgess.buchanan_np

    • Facebook
    • Instagram
    • LinkedIn
    • YouTube
    • TikTok

    © 2025 by Origo Functional Medicine PLLC

    bottom of page